Handelsbanken Fonder Ab Novo Cure LTD Call Options Transaction History
Handelsbanken Fonder Ab
- $25.3 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVCR
# of Institutions
265Shares Held
76.9MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$310 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$302 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$202 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$110 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$77.3 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.68B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...